Author
Harvard UniversityORCID 0009-0000-2610-042XUnclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Shinkichi Takamori, Naoki Haratake, Atrayee Bhattacharya…·Donald W. Kufe
This study identifies M1C as a driver of sotorasib resistance in NSCLC KRAS G12C mutant tumors and shows that targeting M1C improves treatment outcomes.
Maolin Ge, Magdy Gohar, Consuelo Torrini…·Liron Bar‐Peled
The paper identifies oxidative protein states as drivers of metastatic fitness in lung cancer by linking ROS-regulated protein modifications to mitochondrial function and metastasis.
Chendi Li, Varuna Nangia, Melissa D Vieira…·Aaron N. Hata
This study shows that KRASG12C inhibition induces chromosomal instability (CIN) in NSCLC cells, which synergizes with Aurora Kinase A inhibition to enhance therapeutic efficacy.